Although CRP is a very common inflammation marker, in the context of our review, we only found two reported studies that fit our primary inclusion criteria of demonstrating usefulness in the clinic related to pancreatic cancer outcomes; and they had different results. Here, CRP is linked to familial pancreatic carcinoma.